148 related articles for article (PubMed ID: 27365381)
1. Genome-wide microRNA Expression Profiling in Primary Tumors and Matched Liver Metastasis of Patients with Colorectal Cancer.
Vychytilova-Faltejskova P; Pesta M; Radova L; Liska V; Daum O; Kala Z; Svoboda M; Kiss I; Slaby O
Cancer Genomics Proteomics; 2016; 13(4):311-6. PubMed ID: 27365381
[TBL] [Abstract][Full Text] [Related]
2. Differential microRNA expression profiling in primary tumors and matched liver metastasis of patients with colorectal cancer.
Li W; Chang J; Tong D; Peng J; Huang D; Guo W; Zhang W; Li J
Oncotarget; 2017 May; 8(22):35783-35791. PubMed ID: 28415758
[TBL] [Abstract][Full Text] [Related]
3. A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival.
Pecqueux M; Liebetrau I; Werft W; Dienemann H; Muley T; Pfannschmidt J; Müssle B; Rahbari N; Schölch S; Büchler MW; Weitz J; Reissfelder C; Kahlert C
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775664
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression profiles in human colorectal cancers with liver metastases.
Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X
Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058
[TBL] [Abstract][Full Text] [Related]
5. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
[TBL] [Abstract][Full Text] [Related]
6. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.
Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J
Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas.
Gattolliat CH; Uguen A; Pesson M; Trillet K; Simon B; Doucet L; Robaszkiewicz M; Corcos L
Eur J Cancer; 2015 Feb; 51(3):409-20. PubMed ID: 25586944
[TBL] [Abstract][Full Text] [Related]
8. Genomic characterization of liver metastases from colorectal cancer patients.
Sayagués JM; Corchete LA; Gutiérrez ML; Sarasquete ME; Del Mar Abad M; Bengoechea O; Fermiñán E; Anduaga MF; Del Carmen S; Iglesias M; Esteban C; Angoso M; Alcazar JA; García J; Orfao A; Muñoz-Bellvis L
Oncotarget; 2016 Nov; 7(45):72908-72922. PubMed ID: 27662660
[TBL] [Abstract][Full Text] [Related]
9. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
[TBL] [Abstract][Full Text] [Related]
10. Prognostic microRNA expression signature from examination of colorectal primary and metastatic tumors.
Ellermeier C; Vang S; Cleveland K; Durand W; Resnick MB; Brodsky AS
Anticancer Res; 2014 Aug; 34(8):3957-67. PubMed ID: 25075017
[TBL] [Abstract][Full Text] [Related]
11. microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer.
Zhang Y; He X; Liu Y; Ye Y; Zhang H; He P; Zhang Q; Dong L; Liu Y; Dong J
Oncol Rep; 2012 Mar; 27(3):685-94. PubMed ID: 22134529
[TBL] [Abstract][Full Text] [Related]
12. Investigating intra-tumor heterogeneity and expression gradients of miR-21, miR-92a and miR-200c and their potential of predicting lymph node metastases in early colorectal cancer.
Jepsen RK; Novotny GW; Klarskov LL; Christensen IJ; Høgdall E; Riis LB
Exp Mol Pathol; 2016 Oct; 101(2):187-196. PubMed ID: 27565378
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Alternations of MicroRNAs and DNA Methylation Contribute to Liver Metastasis of Colorectal Cancer.
Liu J; Li H; Sun L; Shen S; Zhou Q; Yuan Y; Xing C
Dig Dis Sci; 2019 Jun; 64(6):1523-1534. PubMed ID: 30604369
[TBL] [Abstract][Full Text] [Related]
14. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis.
Pizzini S; Bisognin A; Mandruzzato S; Biasiolo M; Facciolli A; Perilli L; Rossi E; Esposito G; Rugge M; Pilati P; Mocellin S; Nitti D; Bortoluzzi S; Zanovello P
BMC Genomics; 2013 Aug; 14():589. PubMed ID: 23987127
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced microRNA-590-5p promotes colorectal cancer progression by modulating matrix metalloproteinase activity.
Kim CW; Oh ET; Kim JM; Park JS; Lee DH; Lee JS; Kim KK; Park HJ
Cancer Lett; 2018 Mar; 416():31-41. PubMed ID: 29247825
[TBL] [Abstract][Full Text] [Related]
16. Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer.
Qin YZ; Xie XC; Liu HZ; Lai H; Qiu H; Ge LY
Oncol Rep; 2015 Jun; 33(6):2728-36. PubMed ID: 25845814
[TBL] [Abstract][Full Text] [Related]
17. The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer.
Gravgaard KH; Lyng MB; Laenkholm AV; Søkilde R; Nielsen BS; Litman T; Ditzel HJ
Breast Cancer Res Treat; 2012 Jul; 134(1):207-17. PubMed ID: 22294488
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression patterns of tumors in early-onset colorectal cancer patients.
Ak S; Tunca B; Tezcan G; Cecener G; Egeli U; Yilmazlar T; Ozturk E; Yerci O
J Surg Res; 2014 Sep; 191(1):113-22. PubMed ID: 24746948
[TBL] [Abstract][Full Text] [Related]
20. Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer.
Heublein S; Albertsmeier M; Pfeifer D; Loehrs L; Bazhin AV; Kirchner T; Werner J; Neumann J; Angele MK
BMC Cancer; 2018 Feb; 18(1):201. PubMed ID: 29463215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
